孤注一掷的赌局：成本3-5万的自体CAR-T是噱头还是奇迹？丨独家
一个把天价CAR-T成本价降至一五万、售价降到20万的宏大布局
Time：
2023-10-11 09:47
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务